Share

New test can identify both HIV and hepatitis

accreditation
HIV virus from Shutterstock
HIV virus from Shutterstock


US authorities have approved a test developed by Swiss pharmaceutical firm Roche that can detect both HIV and hepatitis viruses, the company said Friday.

Eliminates consecutive rounds of testing

The Cobas Taqscreen MPX is the only test approved by the US Food and Drug Administration that can simultaneously detect the HIV, hepatitis B and C viruses in human blood and plasma, Roche said.

Having a single test eliminates "the need for consecutive rounds of testing" Roche said, stressing that it could shorten the time it takes to reach a crucial diagnosis of the killer viruses.

The human immunodeficiency virus (HIV) which causes Aids, has killed some 39 million people since it emerged in the 1980s.

Hepatitis B and C, which are transmitted from infected mothers to newborn babies by unsafe injections during medical procedures and drug use, or unsafe sex, kill more than a million people each year.

Roche is a leader in the global blood and plasma screening market using so-called nucleic acid-based techniques, which allow earlier detection of virus or bacteria infections in antibody tests.

That market is worth an estimated 660 million euros ($779 million) worldwide.

Read more:

Diagnosing HIV
Testing for HIV
An end to HIV?

Image: HIV virus from Shutterstock

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE